<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(2)</volume><submitter>Weaver DJ</submitter><funding>University of Michigan</funding><pubmed_abstract>&lt;h4>Rationale &amp; objective&lt;/h4>The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control.&lt;h4>Study design&lt;/h4>Retrospective cohort study.&lt;h4>Setting &amp; participants&lt;/h4>Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study.&lt;h4>Exposure&lt;/h4>Proteinuric kidney disease.&lt;h4>Outcomes&lt;/h4>Hypertension and BP control.&lt;h4>Analytical approach&lt;/h4>Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensi</pubmed_abstract><journal>Kidney medicine</journal><pagination>131-138</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7380443</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.</pubmed_title><pmcid>PMC7380443</pmcid><pubmed_authors>Pesenson A</pubmed_authors><pubmed_authors>Weaver DJ</pubmed_authors><pubmed_authors>Oh GJ</pubmed_authors><pubmed_authors>Eikstadt R</pubmed_authors><pubmed_authors>Modes MM</pubmed_authors><pubmed_authors>Troost JP</pubmed_authors><pubmed_authors>Selewski DT</pubmed_authors><pubmed_authors>Attalla SE</pubmed_authors><pubmed_authors>Elliott M</pubmed_authors><pubmed_authors>Waldo A</pubmed_authors><pubmed_authors>Adler S</pubmed_authors><pubmed_authors>Massengill SF</pubmed_authors><pubmed_authors>Gipson DS</pubmed_authors><pubmed_authors>Kamil ES</pubmed_authors><pubmed_authors>Lafayette RA</pubmed_authors><pubmed_authors>Gipson P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.</name><description>&lt;h4>Rationale &amp; objective&lt;/h4>The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control.&lt;h4>Study design&lt;/h4>Retrospective cohort study.&lt;h4>Setting &amp; participants&lt;/h4>Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study.&lt;h4>Exposure&lt;/h4>Proteinuric kidney disease.&lt;h4>Outcomes&lt;/h4>Hypertension and BP control.&lt;h4>Analytical approach&lt;/h4>Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensi</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar-Apr</publication><modification>2025-04-05T13:44:04.079Z</modification><creation>2025-04-05T13:44:04.079Z</creation></dates><accession>S-EPMC7380443</accession><cross_references><pubmed>32734234</pubmed><doi>10.1016/j.xkme.2019.10.012</doi></cross_references></HashMap>